{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T11:17:30Z","timestamp":1742383050811},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,4,23]],"date-time":"2016-04-23T00:00:00Z","timestamp":1461369600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s10689-016-9907-3","type":"journal-article","created":{"date-parts":[[2016,4,23]],"date-time":"2016-04-23T06:31:27Z","timestamp":1461393087000},"page":"651-663","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Increased incidence of bladder cancer, lymphoid leukaemia, and myeloma in a cohort of Queensland melanoma families"],"prefix":"10.1007","volume":"15","author":[{"given":"Jazlyn","family":"Read","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Symmons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane M.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grant W.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas G.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas K.","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,23]]},"reference":[{"issue":"1","key":"9907_CR1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/sj.jid.5700507","volume":"127","author":"AA Larson","year":"2007","unstructured":"Larson AA, Leachman SA, Eliason MJ, Cannon-Albright LA (2007) Population-based assessment of non-melanoma cancer risk in relatives of cutaneous melanoma probands. J Invest Dermatol 127(1):183\u2013188","journal-title":"J Invest Dermatol"},{"issue":"2","key":"9907_CR2","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2133.2011.10350.x","volume":"165","author":"A Brandt","year":"2011","unstructured":"Brandt A, Sundquist J, Hemminki K (2011) Risk of incident and fatal melanoma in individuals with a family history of incident or fatal melanoma or any cancer. Br J Dermatol 165(2):342\u2013348","journal-title":"Br J Dermatol"},{"issue":"15","key":"9907_CR3","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1016\/j.ejca.2014.07.007","volume":"50","author":"T Chen","year":"2014","unstructured":"Chen T, Hemminki K, Kharazmi E, Ji J, Sundquist K, Fallah M (2014) Multiple primary (even in situ) melanomas in a patient pose significant risk to family members. Eur J Cancer 50(15):2659\u20132667","journal-title":"Eur J Cancer"},{"key":"9907_CR4","doi-asserted-by":"crossref","first-page":"12891","DOI":"10.1038\/srep12891","volume":"5","author":"C Frank","year":"2015","unstructured":"Frank C, Fallah M, Sundquist J, Hemminki A (2015) Population landscape of familial cancer. Sci Rep 5:12891","journal-title":"Sci Rep"},{"issue":"9","key":"9907_CR5","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/cncr.20989","volume":"103","author":"RA Kerber","year":"2005","unstructured":"Kerber RA, O\u2019Brien E (2005) A cohort study of cancer risk in relation to family histories of cancer in the Utah population database. Cancer 103(9):1906\u20131915","journal-title":"Cancer"},{"key":"9907_CR6","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1471-2407-12-138","volume":"12","author":"F Albright","year":"2012","unstructured":"Albright F, Teerlink C, Werner TL, Cannon-Albright LA (2012) Significant evidence for a heritable contribution to cancer predisposition: a review of cancer familiality by site. BMC Cancer 12:138","journal-title":"BMC Cancer"},{"issue":"2","key":"9907_CR7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00008390-199604000-00011","volume":"6","author":"JF Aitken","year":"1996","unstructured":"Aitken JF, Green AC, MacLennan R, Youl P, Martin NG (1996) The Queensland Familial Melanoma Project: study design and characteristics of participants. Melanoma Res 6(2):155\u2013165","journal-title":"Melanoma Res"},{"issue":"4","key":"9907_CR8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00008390-199608000-00006","volume":"6","author":"JF Aitken","year":"1996","unstructured":"Aitken JF, Youl P, Green A, MacLennan R, Martin NG (1996) Accuracy of case-reported family history of melanoma in Queensland, Australia. Melanoma Res 6(4):313\u2013317","journal-title":"Melanoma Res"},{"issue":"1","key":"9907_CR9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1158\/1055-9965.EPI-09-0928","volume":"19","author":"CM Olsen","year":"2010","unstructured":"Olsen CM, Carroll HJ, Whiteman DC (2010) Familial melanoma: a meta-analysis and estimates of attributable fraction. Cancer Epidemiol Biomark Prev 19(1):65\u201373","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"9","key":"9907_CR10","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s10552-004-2474-1","volume":"15","author":"CB Begg","year":"2004","unstructured":"Begg CB, Hummer A, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Klotz JB, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Berwick M (2004) Familial aggregation of melanoma risks in a large population-based sample of melanoma cases. Cancer Causes Control 15(9):957\u2013965","journal-title":"Cancer Causes Control"},{"issue":"6","key":"9907_CR11","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/humu.9247","volume":"23","author":"AM Goldstein","year":"2004","unstructured":"Goldstein AM (2004) Familial melanoma, pancreatic cancer and germline CDKN2A mutations. Hum Mutat 23(6):630","journal-title":"Hum Mutat"},{"issue":"2","key":"9907_CR12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/jmg.2006.043802","volume":"44","author":"AM Goldstein","year":"2007","unstructured":"Goldstein AM, Chan M, Harland M, Hayward NK, Demenais F, Bishop DT, Azizi E, Bergman W, Bianchi-Scarra G, Bruno W, Calista D, Albright LA, Chaudru V, Chompret A, Cuellar F, Elder DE, Ghiorzo P, Gillanders EM, Gruis NA, Hansson J, Hogg D, Holland EA, Kanetsky PA, Kefford RF, Landi MT, Lang J, Leachman SA, MacKie RM, Magnusson V, Mann GJ, Bishop JN, Palmer JM, Puig S, Puig-Butille JA, Stark M, Tsao H, Tucker MA, Whitaker L, Yakobson E (2007) Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. J Med Genet 44(2):99\u2013106","journal-title":"J Med Genet"},{"issue":"12","key":"9907_CR13","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/jnci\/djs221","volume":"104","author":"B Mukherjee","year":"2012","unstructured":"Mukherjee B, Delancey JO, Raskin L, Everett J, Jeter J, Begg CB, Orlow I, Berwick M, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Culver HA, Rosso S, Zanetti R, Kanetsky PA, From L, Gruber SB (2012) Risk of non-melanoma cancers in first-degree relatives of CDKN2A mutation carriers. J Natl Cancer Inst 104(12):953\u2013956","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"9907_CR14","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/jmedgenet-2014-102320","volume":"51","author":"H Helgadottir","year":"2014","unstructured":"Helgadottir H, Hoiom V, Jonsson G, Tuominen R, Ingvar C, Borg A, Olsson H, Hansson J (2014) High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families. J Med Genet 51(8):545\u2013552","journal-title":"J Med Genet"},{"issue":"7375","key":"9907_CR15","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature10539","volume":"480","author":"C Bertolotto","year":"2011","unstructured":"Bertolotto C, Lesueur F, Giuliano S, Strub T, deLichy M, Bille K, Dessen P, d\u2019Hayer B, Mohamdi H, Remenieras A, Maubec E, de la Fouchardiere A, Molinie V, Vabres P, Dalle S, Poulalhon N, Martin-Denavit T, Thomas L, Andry-Benzaquen P, Dupin N, Boitier F, Rossi A, Perrot JL, Labeille B, Robert C, Escudier B, Caron O, Brugieres L, Saule S, Gardie B, Gad S, Richard S, Couturier J, Teh BT, Ghiorzo P, Pastorino L, Puig S, Badenas C, Olsson H, Ingvar C, Rouleau E, Lidereau R, Bahadoran P, Vielh P, Corda E, Blanche H, Zelenika D, Galan P, Aubin F, Bachollet B, Becuwe C, Berthet P, Bignon YJ, Bonadona V, Bonafe JL, Bonnet-Dupeyron MN, Cambazard F, Chevrant-Breton J, Coupier I, Dalac S, Demange L, d\u2019Incan M, Dugast C, Faivre L, Vincent-Fetita L, Gauthier-Villars M, Gilbert B, Grange F, Grob JJ, Humbert P, Janin N, Joly P, Kerob D, Lasset C, Leroux D, Levang J, Limacher JM, Livideanu C, Longy M, Lortholary A, Stoppa-Lyonnet D, Mansard S, Mansuy L, Marrou K, Mateus C, Maugard C, Meyer N, Nogues C, Souteyrand P, Venat-Bouvet L, Zattara H, Chaudru V, Lenoir GM, Lathrop M, Davidson I, Avril MF, Demenais F, Ballotti R, Bressac-de Paillerets B (2011) A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma. Nature 480(7375):94\u201398","journal-title":"Nature"},{"key":"9907_CR16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1479-5876-10-179","volume":"10","author":"M Carbone","year":"2012","unstructured":"Carbone M, Ferris LK, Baumann F, Napolitano A, Lum CA, Flores EG, Gaudino G, Powers A, Bryant-Greenwood P, Krausz T, Hyjek E, Tate R, Friedberg J, Weigel T, Pass HI, Yang H (2012) BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs. J Transl Med 10:179","journal-title":"J Transl Med"},{"issue":"3","key":"9907_CR17","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/cge.12472","volume":"88","author":"A Fouchardiere de la","year":"2014","unstructured":"de la Fouchardiere A, Cabaret O, Savin L, Combemale P, Schvartz H, Penet C, Bonadona V, Soufir N, Bressac-de Paillerets B (2014) Germline BAP1 mutations predispose also to multiple basal cell carcinomas. Clin Genet 88(3):273\u2013277","journal-title":"Clin Genet"},{"issue":"2","key":"9907_CR18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/pcmr.12047","volume":"26","author":"P Ghiorzo","year":"2013","unstructured":"Ghiorzo P, Pastorino L, Queirolo P, Bruno W, Tibiletti MG, Nasti S, Andreotti V, Paillerets BB, Bianchi Scarra G (2013) Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history. Pigment Cell Melanoma Res 26(2):259\u2013262","journal-title":"Pigment Cell Melanoma Res"},{"issue":"4","key":"9907_CR19","doi-asserted-by":"crossref","first-page":"e35295","DOI":"10.1371\/journal.pone.0035295","volume":"7","author":"CN Njauw","year":"2012","unstructured":"Njauw CN, Kim I, Piris A, Gabree M, Taylor M, Lane AM, DeAngelis MM, Gragoudas E, Duncan LM, Tsao H (2012) Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families. PLoS One 7(4):e35295","journal-title":"PLoS One"},{"issue":"6","key":"9907_CR20","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ajhg.2013.04.012","volume":"92","author":"T Popova","year":"2013","unstructured":"Popova T, Hebert L, Jacquemin V, Gad S, Caux-Moncoutier V, Dubois-d\u2019Enghien C, Richaudeau B, Renaudin X, Sellers J, Nicolas A, Sastre-Garau X, Desjardins L, Gyapay G, Raynal V, Sinilnikova OM, Andrieu N, Manie E, de Pauw A, Gesta P, Bonadona V, Maugard CM, Penet C, Avril MF, Barillot E, Cabaret O, Delattre O, Richard S, Caron O, Benfodda M, Hu HH, Soufir N, Soufir N, Bressac-de Paillerets B, Stern MH (2013) Germline BAP1 mutations predispose to renal cell carcinomas. Am J Hum Genet 92(6):974\u2013980","journal-title":"Am J Hum Genet"},{"key":"9907_CR21","doi-asserted-by":"crossref","unstructured":"Robles-Espinoza CD, Harland M, Ramsay AJ, Aoude LG, Quesada V, Ding Z, Pooley KA, Pritchard AL, Tiffen JC, Petljak M, Palmer JM, Symmons J, Johansson P. (2014) POT1 loss-of-function variants predispose to familial melanoma. Nat Genet\u00a046(5):478\u2013481","DOI":"10.1038\/ng.2947"},{"key":"9907_CR22","doi-asserted-by":"crossref","unstructured":"Shi J, Yang XR, Ballew B, Rotunno M, Calista D, Fargnoli MC, Ghiorzo P, Bressac-de Paillerets B, Nagore E, Avril MF, Caporaso NE, McMaster ML, Cullen M, Wang Z, Zhang X, Bruno W, Pastorino L, Queirolo P, Banuls-Roca J, Garcia-Casado Z, Vaysse A, Mohamdi H, Riazalhosseini Y, Foglio M, Jouenne F, Hua X, Hyland PL, Yin J, Vallabhaneni H, Chai W, Minghetti P, Pellegrini C, Ravichandran S, Eggermont A, Lathrop M, Peris K, Scarra GB, Landi G, Savage SA, Sampson JN, He J, Yeager M, Goldin LR, Demenais F (2014) Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma. Nat Genet\u00a046(5):482\u2013486","DOI":"10.1038\/ng.2941"},{"issue":"10","key":"9907_CR23","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","volume":"43","author":"JR Testa","year":"2011","unstructured":"Testa JR, Cheung M, Pei J, Below JE, Tan Y, Sementino E, Cox NJ, Dogan AU, Pass HI, Trusa S, Hesdorffer M, Nasu M, Powers A, Rivera Z, Comertpay S, Tanji M, Gaudino G, Yang H, Carbone M (2011) Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet 43(10):1022\u20131025","journal-title":"Nat Genet"},{"issue":"10","key":"9907_CR24","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/ng.910","volume":"43","author":"T Wiesner","year":"2011","unstructured":"Wiesner T, Obenauf AC, Murali R, Fried I, Griewank KG, Ulz P, Windpassinger C, Wackernagel W, Loy S, Wolf I, Viale A, Lash AE, Pirun M, Socci ND, Rutten A, Palmedo G, Abramson D, Offit K, Ott A, Becker JC, Cerroni L, Kutzner H, Bastian BC, Speicher MR (2011) Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet 43(10):1018\u20131021","journal-title":"Nat Genet"},{"issue":"7375","key":"9907_CR25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature10630","volume":"480","author":"S Yokoyama","year":"2011","unstructured":"Yokoyama S, Woods SL, Boyle GM, Aoude LG, MacGregor S, Zismann V, Gartside M, Cust AE, Haq R, Harland M, Taylor JC, Duffy DL, Holohan K, Dutton-Regester K, Palmer JM, Bonazzi V, Stark MS, Symmons J, Law MH, Schmidt C, Lanagan C, O\u2019Connor L, Holland EA, Schmid H, Maskiell JA, Jetann J, Ferguson M, Jenkins MA, Kefford RF, Giles GG, Armstrong BK, Aitken JF, Hopper JL, Whiteman DC, Pharoah PD, Easton DF, Dunning AM, Newton-Bishop JA, Montgomery GW, Martin NG, Mann GJ, Bishop DT, Tsao H, Trent JM, Fisher DE, Hayward NK, Brown KM (2011) A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. Nature 480(7375):99\u2013103","journal-title":"Nature"},{"issue":"2","key":"9907_CR26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1375\/twin.11.2.183","volume":"11","author":"AJ Baxter","year":"2008","unstructured":"Baxter AJ, Hughes MC, Kvaskoff M, Siskind V, Shekar S, Aitken JF, Green AC, Duffy DL, Hayward NK, Martin NG, Whiteman DC (2008) The Queensland study of Melanoma: environmental and Genetic Associations (Q-MEGA). Study design, baseline characteristics, and repeatability of phenotype and sun exposure measures. Twin Res Hum Genet 11(2):183\u2013196","journal-title":"Twin Res Hum Genet"},{"key":"9907_CR27","unstructured":"Cancer_Council_Queensland. Methodology. http:\/\/www.cancerqld.org.au\/page\/research_statistics\/queensland_cancer_statistics\/queensland_cancer_statistics_online_qcsol\/methodology\/"},{"key":"9907_CR28","unstructured":"Cancer_Council_Queensland. Average annual age-specific incidence of all invasive cancers by sex, Queensland, 2008\u20132012. http:\/\/www.cancerqld.org.au\/f\/QCSOL\/View\/Incidence_(Diagnosis)\/Age_Specific\/All_Invasive_Cancers"},{"key":"9907_CR29","unstructured":"Cancer_Council_Queensland. Incidence rate trends for all invasive cancers by sex, Queensland, 1982\u20132012. [cited 2015]. http:\/\/www.cancerqld.org.au\/f\/QCSOL\/View\/Incidence_(Diagnosis)\/Trends_Over_Time\/All_Invasive_Cancers\/By_Sex"},{"key":"9907_CR30","unstructured":"Cancer_Council_Queensland. Recent trends (annual percentage change) in incidence rates for common cancers in Queensland. http:\/\/www.cancerqld.org.au\/f\/QCSOL\/View\/Incidence_(Diagnosis)\/Trends_Over_Time\/Overview"},{"issue":"7","key":"9907_CR31","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/sj.bjc.6605325","volume":"101","author":"JL Bermejo","year":"2009","unstructured":"Bermejo JL, Sundquist J, Hemminki K (2009) Bladder cancer in cancer patients: population-based estimates from a large Swedish study. Br J Cancer 101(7):1091\u20131099","journal-title":"Br J Cancer"},{"issue":"6122","key":"9907_CR32","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1230062","volume":"339","author":"S Horn","year":"2013","unstructured":"Horn S, Figl A, Rachakonda PS, Fischer C, Sucker A, Gast A, Kadel S, Moll I, Nagore E, Hemminki K, Schadendorf D, Kumar R (2013) TERT promoter mutations in familial and sporadic melanoma. Science 339(6122):959\u2013961","journal-title":"Science"},{"issue":"43","key":"9907_CR33","doi-asserted-by":"crossref","first-page":"17426","DOI":"10.1073\/pnas.1310522110","volume":"110","author":"PS Rachakonda","year":"2013","unstructured":"Rachakonda PS, Hosen I, de Verdier PJ, Fallah M, Heidenreich B, Ryk C, Wiklund NP, Steineck G, Schadendorf D, Hemminki K, Kumar R (2013) TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism. Proc Natl Acad Sci USA 110(43):17426\u201317431","journal-title":"Proc Natl Acad Sci USA"},{"issue":"18","key":"9907_CR34","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1158\/1078-0432.CCR-14-0330","volume":"20","author":"ML Nickerson","year":"2014","unstructured":"Nickerson ML, Dancik GM, Im KM, Edwards MG, Turan S, Brown J, Ruiz-Rodriguez C, Owens C, Costello JC, Guo G, Tsang SX, Li Y, Zhou Q, Cai Z, Moore LE, Lucia MS, Dean M, Theodorescu D (2014) Concurrent alterations in TERT, KDM6A, and the BRCA pathway in bladder cancer. Clin Cancer Res 20(18):4935\u20134948","journal-title":"Clin Cancer Res"},{"issue":"6122","key":"9907_CR35","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1126\/science.1229259","volume":"339","author":"FW Huang","year":"2013","unstructured":"Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA (2013) Highly recurrent TERT promoter mutations in human melanoma. Science 339(6122):957\u2013959","journal-title":"Science"},{"issue":"11","key":"9907_CR36","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/ng.687","volume":"42","author":"N Rothman","year":"2010","unstructured":"Rothman N, Garcia-Closas M, Chatterjee N, Malats N, Wu X, Figueroa JD, Real FX, Van Den Berg D, Matullo G, Baris D, Thun M, Kiemeney LA, Vineis P, De Vivo I, Albanes D, Purdue MP, Rafnar T, Hildebrandt MA, Kiltie AE, Cussenot O, Golka K, Kumar R, Taylor JA, Mayordomo JI, Jacobs KB, Kogevinas M, Hutchinson A, Wang Z, Fu YP, Prokunina-Olsson L, Burdett L, Yeager M, Wheeler W, Tardon A, Serra C, Carrato A, Garcia-Closas R, Lloreta J, Johnson A, Schwenn M, Karagas MR, Schned A, Andriole G Jr, Grubb R 3rd, Black A, Jacobs EJ, Diver WR, Gapstur SM, Weinstein SJ, Virtamo J, Cortessis VK, Gago-Dominguez M, Pike MC, Stern MC, Yuan JM, Hunter DJ, McGrath M, Dinney CP, Czerniak B, Chen M, Yang H, Vermeulen SH, Aben KK, Witjes JA, Makkinje RR, Sulem P, Besenbacher S, Stefansson K, Riboli E, Brennan P, Panico S, Navarro C, Allen NE, Bueno-de-Mesquita HB, Trichopoulos D, Caporaso N, Landi MT, Canzian F, Ljungberg B, Tjonneland A, Clavel-Chapelon F, Bishop DT, Teo MT, Knowles MA, Guarrera S, Polidoro S, Ricceri F, Sacerdote C, Allione A, Cancel-Tassin G, Selinski S, Hengstler JG, Dietrich H, Fletcher T, Rudnai P, Gurzau E, Koppova K, Bolick SC, Godfrey A, Xu Z, Sanz-Velez JI, D Garc\u00eda-Prats M, Sanchez M, Valdivia G, Porru S, Benhamou S, Hoover RN, Fraumeni JF Jr, Silverman DT, Chanock SJ (2010) A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet 42(11):978\u2013984","journal-title":"Nat Genet"},{"issue":"5","key":"9907_CR37","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.urolonc.2008.02.016","volume":"26","author":"CM Mueller","year":"2008","unstructured":"Mueller CM, Caporaso N, Greene MH (2008) Familial and genetic risk of transitional cell carcinoma of the urinary tract. Urol Oncol 26(5):451\u2013464","journal-title":"Urol Oncol"},{"issue":"3","key":"9907_CR38","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0022-5347(01)66380-8","volume":"155","author":"M Schoenberg","year":"1996","unstructured":"Schoenberg M, Kiemeney L, Walsh PC, Griffin CA, Sidransky D (1996) Germline translocation t(5;20) (p15;q11) and familial transitional cell carcinoma. J Urol 155(3):1035\u20131036","journal-title":"J Urol"},{"issue":"1","key":"9907_CR39","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1464-410X.2007.07192.x","volume":"101","author":"YJ Shen","year":"2008","unstructured":"Shen YJ, Ye DW, Yao XD, Trink B, Zhou XY, Zhang SL, Dai B, Zhang HL, Zhu Y, Guo Z, Wu G, Nagpal J (2008) Overexpression of CDC91L1 (PIG-U) in bladder urothelial cell carcinoma: correlation with clinical variables and prognostic significance. BJU Int 101(1):113\u2013119","journal-title":"BJU Int"},{"issue":"7","key":"9907_CR40","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2011.1142","volume":"306","author":"ND Freedman","year":"2011","unstructured":"Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC (2011) Association between smoking and risk of bladder cancer among men and women. JAMA 306(7):737\u2013745","journal-title":"JAMA"},{"issue":"4","key":"9907_CR41","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ejca.2010.10.007","volume":"47","author":"K Dietrich","year":"2011","unstructured":"Dietrich K, Demidenko E, Schned A, Zens M, Heaney J, Karagas M (2011) Parity, early menopause and the incidence of bladder cancer in women: a case-control study and meta-analysis. Eur J Cancer 47(4):592\u2013599","journal-title":"Eur J Cancer"},{"issue":"1","key":"9907_CR42","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/sj.bjc.6600692","volume":"88","author":"DB McKenna","year":"2003","unstructured":"McKenna DB, Stockton D, Brewster DH, Doherty VR (2003) Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland. Br J Cancer 88(1):74\u201378","journal-title":"Br J Cancer"},{"issue":"7","key":"9907_CR43","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/bjc.2011.313","volume":"105","author":"JA Royle","year":"2011","unstructured":"Royle JA, Baade PD, Joske D, Girschik J, Fritschi L (2011) Second cancer incidence and cancer mortality among chronic lymphocytic leukaemia patients: a population-based study. Br J Cancer 105(7):1076\u20131081","journal-title":"Br J Cancer"},{"issue":"8","key":"9907_CR44","doi-asserted-by":"crossref","first-page":"e287","DOI":"10.1111\/ijd.12564","volume":"54","author":"JD Brewer","year":"2015","unstructured":"Brewer JD, Shanafelt TD, Call TG, Cerhan JR, Roenigk RK, Weaver AL, Otley CC (2015) Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia. Int J Dermatol 54(8):e287\u2013e293","journal-title":"Int J Dermatol"},{"issue":"1","key":"9907_CR45","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jaad.2014.09.030","volume":"72","author":"S Famenini","year":"2015","unstructured":"Famenini S, Martires KJ, Zhou H, Xavier MF, Wu JJ (2015) Melanoma in patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma. J Am Acad Dermatol 72(1):78\u201384","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"9907_CR46","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.cell.2007.03.043","volume":"129","author":"A Raval","year":"2007","unstructured":"Raval A, Tanner SM, Byrd JC, Angerman EB, Perko JD, Chen SS, Hackanson B, Grever MR, Lucas DM, Matkovic JJ, Lin TS, Kipps TJ, Murray F, Weisenburger D, Sanger W, Lynch J, Watson P, Jansen M, Yoshinaga Y, Rosenquist R, de Jong PJ, Coggill P, Beck S, Lynch H, de la Chapelle A, Plass C (2007) Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell 129(5):879\u2013890","journal-title":"Cell"},{"issue":"1","key":"9907_CR47","doi-asserted-by":"crossref","first-page":"e55261","DOI":"10.1371\/journal.pone.0055261","volume":"8","author":"QX Wei","year":"2013","unstructured":"Wei QX, Claus R, Hielscher T, Mertens D, Raval A, Oakes CC, Tanner SM, de la Chapelle A, Byrd JC, Stilgenbauer S, Plass C (2013) Germline allele-specific expression of DAPK1 in chronic lymphocytic leukemia. PLoS One 8(1):e55261","journal-title":"PLoS One"},{"issue":"5","key":"9907_CR48","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/ng.2584","volume":"45","author":"AJ Ramsay","year":"2013","unstructured":"Ramsay AJ, Quesada V, Foronda M, Conde L, Martinez-Trillos A, Villamor N, Rodriguez D, Kwarciak A, Garabaya C, Gallardo M, Lopez-Guerra M, Lopez-Guillermo A, Puente XS, Blasco MA, Campo E, Lopez-Otin C (2013) POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia. Nat Genet 45(5):526\u2013530","journal-title":"Nat Genet"},{"issue":"6","key":"9907_CR49","doi-asserted-by":"crossref","first-page":"e100683","DOI":"10.1371\/journal.pone.0100683","volume":"9","author":"LG Aoude","year":"2014","unstructured":"Aoude LG, Xu M, Zhao ZZ, Kovacs M, Palmer JM, Johansson P, Symmons J, Trent JM, Martin NG, Montgomery GW, Brown KM, Hayward NK (2014) Assessment of PALB2 as a candidate melanoma susceptibility gene. PLoS One 9(6):e100683","journal-title":"PLoS One"},{"issue":"5","key":"9907_CR50","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3324\/haematol.2009.006296","volume":"94","author":"D Crowther-Swanepoel","year":"2009","unstructured":"Crowther-Swanepoel D, Houlston RS (2009) The molecular basis of familial chronic lymphocytic leukemia. Haematologica 94(5):606\u2013609","journal-title":"Haematologica"},{"issue":"11","key":"9907_CR51","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.ejca.2005.11.033","volume":"42","author":"A Altieri","year":"2006","unstructured":"Altieri A, Chen B, Bermejo JL, Castro F, Hemminki K (2006) Familial risks and temporal incidence trends of multiple myeloma. Eur J Cancer 42(11):1661\u20131670","journal-title":"Eur J Cancer"},{"key":"9907_CR52","doi-asserted-by":"crossref","unstructured":"Frank C, Fallah M, Chen T, Mai EK, Sundquist J, Forsti A, Hemminki K (2016) Search for familial clustering of multiple myeloma with any cancer. Leukemia 30:627\u2013632","DOI":"10.1038\/leu.2015.279"},{"issue":"5","key":"9907_CR53","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1182\/blood.V95.5.1869.005k09_1869_1871","volume":"95","author":"D Dilworth","year":"2000","unstructured":"Dilworth D, Liu L, Stewart AK, Berenson JR, Lassam N, Hogg D (2000) Germline CDKN2A mutation implicated in predisposition to multiple myeloma. Blood 95(5):1869\u20131871","journal-title":"Blood"},{"issue":"1","key":"9907_CR54","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/ng.993","volume":"44","author":"P Broderick","year":"2012","unstructured":"Broderick P, Chubb D, Johnson DC, Weinhold N, Forsti A, Lloyd A, Olver B, Ma YP, Dobbins SE, Walker BA, Davies FE, Gregory WA, Child JA, Ross FM, Jackson GH, Neben K, Jauch A, Hoffmann P, Muhleisen TW, Nothen MM, Moebus S, Tomlinson IP, Goldschmidt H, Hemminki K, Morgan GJ, Houlston RS (2012) Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk. Nat Genet 44(1):58\u201361","journal-title":"Nat Genet"},{"key":"9907_CR55","doi-asserted-by":"crossref","unstructured":"Chubb D, Weinhold N, Broderick P, Chen B, Johnson DC (2013) Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk. Nat Genet 45(10):1221\u20131225","DOI":"10.1038\/ng.2733"},{"issue":"3","key":"9907_CR56","first-page":"518","volume":"28","author":"GJ Morgan","year":"2014","unstructured":"Morgan GJ, Johnson DC, Weinhold NGH, Landgren O, Lynch HT, Hemminki K, Houlston RS (2014) Inherited genetic susceptibility to multiple myeloma. 28(3):518\u2013524","journal-title":"Inherited genetic susceptibility to multiple myeloma."},{"issue":"2","key":"9907_CR57","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/10428194.2010.529207","volume":"52","author":"J Hasskarl","year":"2011","unstructured":"Hasskarl J, Ihorst G, De Pasquale D, Schrottner P, Zerweck A, Wasch R, Engelhardt M (2011) Association of multiple myeloma with different neoplasms: systematic analysis in consecutive patients with myeloma. Leuk Lymphoma 52(2):247\u2013259","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"9907_CR58","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1158\/1055-9965.EPI-06-0414","volume":"15","author":"LB Travis","year":"2006","unstructured":"Travis LB (2006) The epidemiology of second primary cancers. Cancer Epidemiol Biomark Prev 15(11):2020\u20132026","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"1","key":"9907_CR59","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1365-2133.2000.03610.x","volume":"143","author":"DB McKenna","year":"2000","unstructured":"McKenna DB, Doherty VR, McLaren KM, Hunter JA (2000) Malignant melanoma and lymphoproliferative malignancy: is there a shared aetiology? Br J Dermatol 143(1):171\u2013173","journal-title":"Br J Dermatol"},{"issue":"10","key":"9907_CR60","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s10552-007-9048-y","volume":"18","author":"SR Silver","year":"2007","unstructured":"Silver SR, Hiratzka SL, Schubauer-Berigan MK, Daniels RD (2007) Chronic lymphocytic leukemia radiogenicity: a systematic review. Cancer Causes Control 18(10):1077\u20131093","journal-title":"Cancer Causes Control"},{"issue":"10","key":"9907_CR61","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1002\/cncr.25067","volume":"116","author":"JD Wright","year":"2010","unstructured":"Wright JD, St Clair CM, Deutsch I, Burke WM, Gorrochurn P, Sun X, Herzog TJ (2010) Pelvic radiotherapy and the risk of secondary leukemia and multiple myeloma. Cancer 116(10):2486\u20132492","journal-title":"Cancer"},{"issue":"6","key":"9907_CR62","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/jmg.2004.019349","volume":"41","author":"AM Goldstein","year":"2004","unstructured":"Goldstein AM, Struewing JP, Fraser MC, Smith MW, Tucker MA (2004) Prospective risk of cancer in CDKN2A germline mutation carriers. J Med Genet 41(6):421\u2013424","journal-title":"J Med Genet"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-016-9907-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-016-9907-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-016-9907-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T22:57:22Z","timestamp":1718492242000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-016-9907-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,23]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["9907"],"URL":"https:\/\/doi.org\/10.1007\/s10689-016-9907-3","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,23]]}}}